GleamWall
中文EN

ONCO Onconetix, Inc.

Pharmaceutical Preparations · Nasdaq · SEC CIK 1782107 · Fiscal year ends 12/31

Financial factors as of 2026-06-30 (2026Q2), TTM = sum of the last four quarters

Growth

TTM revenue YoY-51.3%
TTM net income YoY76.9%
TTM EPS YoY216.9%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin80.4%
Operating margin-2,525.0%
Net margin-1,578.8%
FCF margin—
EBITDA margin-2,522.7%

Returns

ROE-105.2%
ROA-57.4%
ROIC (approx.)-195.9%
Asset turnover0.04x

Leverage & solvency

Liabilities / assets18.0%
Debt / equity0.00x
Current ratio2.21x
Interest coverage-52.44x

Cash quality & payout

Operating cash flow / net income1.01x
Accruals ratio0.6%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$815,371$2.52M
Cost of revenue$182,458$1.47M
Gross profit$632,913$1.06M
R&D expense—$154,359
SG&A expense$7.04M$11.23M
Operating income-$17.86M-$56.49M
Interest expense$751,005$873,433
Pretax income-$14.03M-$59.74M
Income tax$525-$1.05M
Net income-$14.03M-$58.69M
EBITDA-$17.84M-$55.76M
EPS (basic)-16.56-1,823.39
EPS (diluted)-16.56-1,823.39
Weighted avg. shares (diluted)937,69032,301
Banking
Deposits—$3.50M
Balance sheet
Cash & equivalents$5.22M$646,500
Receivables$296,866$25,717
Inventory$149,961$64,079
Current assets$6.07M$950,267
PP&E, net$37,085$62,896
Goodwill$18.55M$18.55M
Total assets$24.93M$28.18M
Current liabilities$9.14M$18.29M
Total liabilities$9.16M$18.57M
Shareholders' equity$15.76M$8.54M
Shares outstanding31,198138,270
Cash flow statement
Operating cash flow-$9.68M-$10.50M
Capital expenditure—$28,471
Free cash flow—-$10.52M
Investing cash flow—-$28,471
Financing cash flow$14.45M$6.74M
Depreciation & amortization$15,170$731,345
Stock-based compensation$74,267$438,653

Free plan shows the latest 2 periods; Pro shows all 5 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.